Extract

This study will assess the safety and efficacy of secukinumab compared to placebo and etanercept in patients that have moderate to severe, chronic, plaque-type psoriasis.

Inclusion criteria

• Chronic plaque psoriasis

Country

• Argentina
• Australia
• Belgium
• Canada
• Colombia
• Egypt
• Finland
• France
• Germany
• Guatemala
• Hungary
• Iceland
• India
• Italy
• Korea, Republic of
• Philippines
• Poland
• Romania
• Singapore
• Spain
• Sweden
• United Kingdom
• United States

Links

• ictrp
• nct